Topics

Chemistry & Life Sciences

Expert Statement: Frank Ferrante, Cambrex

20.09.2024 -

The evolution of the CDMO sector is propelled by rising manufacturing standards, the advent of groundbreaking therapies, and a shift towards personalized medicine.

Chemistry & Life Sciences

Increasing Gap in Biotech Venture Funding

11.09.2024 -

Consulting firm BCG has evaluated the effectiveness of biotech innovation centers in Europe and the USA. Adolphs explains what is lacking in Germany in particular.

Markets & Companies

Insights into Biologics and Pharmaceutical Manufacturing

11.09.2024 -

Bill Humphries, CEO of Alcami, shares his vision for the future, discussing dynamic market trends and the company’s commitment to innovation. Under his leadership, Alcami...

Chemistry & Life Sciences

Uncovering Potential

11.09.2024 -

Interview with Olivier Lambrechts, executive leadership team member and president NCE at Arxada.

Markets & Companies

Flow Chemistry — The Right Tool for CDMOs

11.09.2024 -

For CDMOs, the adoption of flow chemistry can provide a competitive advantage by improving efficiency, safety and quality, while reducing costs and development times.

Chemistry & Life Sciences

The Evolution of the CDMO Industry

11.09.2024 -

The evolution of the CDMO sector is propelled by rising manufacturing standards, the advent of groundbreaking therapies, and a shift towards personalized medicine...

Markets & Companies

Chemical Labor Productivity Challenge

11.09.2024 -

The chemical industry faces acute labor shortages because the talent pool is shrinking, but the industry remains heavily reliant on manual work. Therefore, realizing...

Chemistry & Life Sciences

Expert Statement: Gordon Bates, Lonza

02.09.2024 -

The evolution of the CDMO sector is propelled by rising manufacturing standards, the advent of groundbreaking therapies, and a shift towards personalized medicine.